id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0108-0008,FDA,FDA-2000-N-0108,"Tab B - ""OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 79-174)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:17:41Z,,0,0,09000064804c2946
FDA-2000-N-0108-0012,FDA,FDA-2000-N-0108,"Tab A - ""OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 200-307)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:34:12Z,,0,0,09000064804c2951
FDA-2000-N-0108-0018,FDA,FDA-2000-N-0108,"Tab A - ""OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 308-406)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:36:23Z,,0,0,09000064804c2967
FDA-2000-N-0108-0013,FDA,FDA-2000-N-0108,"Tab B - ""OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 377-464)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:27:30Z,,0,0,09000064804c2954
FDA-2000-N-0108-0017,FDA,FDA-2000-N-0108,"Tab B - ""OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 278-376)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:21:09Z,,0,0,09000064804c2964
FDA-2000-N-0108-0015,FDA,FDA-2000-N-0108,"Tab B - ""OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA"" -  (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 1-78)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:11:52Z,,0,0,09000064804c295e
FDA-2000-N-0108-0011,FDA,FDA-2000-N-0108,"Tab A - ""OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 100-199)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:32:47Z,,0,0,09000064804c294e
FDA-2000-N-0108-0009,FDA,FDA-2000-N-0108,"Reference Regulations Policy Management Staff to the Docket, OMB Review March 14, 2003, Executive Order 12866"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2016-02-24T16:51:58Z,,0,0,09000064804c294a
FDA-2000-N-0108-0016,FDA,FDA-2000-N-0108,"Tab B - ""OMB Review March 14, 2003, Executive Order 12866, Changes in the Regulatory Action Made by OIRA"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 175-277)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:19:39Z,,0,0,09000064804c2961
FDA-2000-N-0108-0014,FDA,FDA-2000-N-0108,"Tab A - ""OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 407-464)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:35:14Z,,0,0,09000064804c2957
FDA-2000-N-0108-0010,FDA,FDA-2000-N-0108,"Tab A - ""OMB Review March 14, 2003, Executive Order 12866, Substantive Changes Between the Draft Submitted to OIRA and Action Subsequently Announced"" - (Safety Reporting Requirements for Human Drug and Biological Products), re FDA-2000-N-0108-0006 - Reference (Pages 1-99)",Supporting & Related Material,REF-Reference (internal unless indicated),2003-11-03T05:00:00Z,2003,11,,,2010-02-26T21:16:06Z,,0,0,09000064804c294b
FDA-2000-N-0108-0007,FDA,FDA-2000-N-0108,Safety Reporting Requirements for Human Drug and Biological Products; Extension of Comment Period,Proposed Rule,NEC-Notice of Extension,2003-07-01T04:00:00Z,2003,7,2003-06-17T04:00:00Z,2003-10-15T03:59:59Z,2016-12-21T02:02:24Z,,0,0,09000064804c2749
FDA-2000-N-0108-0001,FDA,FDA-2000-N-0108,Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products See FDA-2000-N-0108-0006,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-03-18T05:00:00Z,2003,3,2003-03-18T05:00:00Z,2003-07-15T03:59:59Z,2016-12-24T19:42:06Z,,0,0,09000064804c265e
FDA-2000-N-0108-0006,FDA,FDA-2000-N-0108,Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-03-18T05:00:00Z,2003,3,2003-03-18T05:00:00Z,2003-07-15T03:59:59Z,2016-02-24T19:29:20Z,,0,0,09000064804c2702
FDA-2000-N-0108-0004,FDA,FDA-2000-N-0108,See FDA-2000-N-0108-0006,Supporting & Related Material,,2003-03-18T00:00:00Z,2003,3,,,2016-03-02T20:20:20Z,,0,1,09000064804c26fd
FDA-2000-N-0108-0002,FDA,FDA-2000-N-0108,See FDA-2000-N-0108-0006,Supporting & Related Material,,2003-03-18T00:00:00Z,2003,3,,,2016-02-24T19:16:56Z,,0,1,09000064804c26f7
FDA-2000-N-0108-0003,FDA,FDA-2000-N-0108,See FDA-2000-N-0108-0006,Proposed Rule,,2003-03-18T00:00:00Z,2003,3,,,2016-03-02T20:23:54Z,,0,1,09000064804c26fb
FDA-2000-N-0108-0005,FDA,FDA-2000-N-0108,See FDA-2000-N-0108-0006,Supporting & Related Material,,2003-03-18T00:00:00Z,2003,3,,,2016-03-02T19:41:42Z,,0,1,09000064804c2700